Gine & Obstretica Step up 2 Flashcards
Fetal to 4 yrs - Hormone Levels and Characteristics
High intrauterine FSH and LH that peak at 20-wk gestation and decrease until birth
FSH and LH increase again from birth until 6 mo of age then gradually decrease to low levels by age 4 yrs
Ch
All oocytes formed and partially matured by 20-wk gestation Tanner stage 1 characteristics
4–8 yrs - Hormone Levels and Characteristics
Low FSH, LH, and androgen levels caused by GnRH
suppression
Ch
Tanner stage 1 characteristics
Any sexual development considered precocious
11–17 yrs - Hormone Levels and Characteristics
Further increase of LH, FSH, and androgens to baseline mature levels
Hormones secreted in pulsatile fashion (higher at night) caused by sleep-associated increase in GnRH secretion
Ch
Puberty
Progression through Tanner stages
Development of secondary sexual characteristics and growth spurt
Menarche in females (beginning of menstrual cycles) and further oocyte maturation
17–50 yrs (females) - Hormone Levels and Characteristics
LH and FSH follow menstrual cycle Gradual increase in FSH and LH with ovarian insensitivity Ch Menstrual cycles Mature sexual characteristics
≥50 yrs (females) - Hormone Levels and Characteristics
LH and FSH levels increase with onset of ovarian failure
Ch
Perimenopause: menstrual cycles become inconsistent
(oligomenorrhea)
Menopause: menstrual cycles cease (amenorrhea)
Which is the mean age of menarche? Are there differences between races?
The mean age of menarche is 13 years in the United States and tends to occur earlier in blacks than in whites
Which is the order of events in female puberty
Order of events of normal female puberty: adrenarche (adrenal androgen production), gonadarche (activation of gonads by FSH and LH), thelarche (appearance of breast tissue), pubarche (appearance of pubic hair), growth spurt, menarche (onset of menses).
Tanner Stage 1
Breast Development
Prepubertal: raised papilla (nipple) only
Pubic Hair Development
Prepubertal: no hair growth
Tanner Stage 2
Breast Development
Breast budding, areolar enlargement
Pubic Hair Development
Slight growth of fine labial hair
Tanner Stage 3
Breast Development
Further breast and areolar enlargement
Pubic Hair Development
Further growth of hair
Tanner Stage 4
Breast Development
Further breast enlargement: areola and papilla form secondary growth above the level of breast
Pubic Hair Development
Hair becomes coarser and spreads over much of pubic region
Tanner Stage 5
Breast Development
Mature breast: areola recedes to the level of the breast while papilla remains extended
Pubic Hair Development
Coarse hair extends from the pubic region to the medial thighs
Types of Precocious Puberty and Meaning
Isosexual
- Premature sexual development appropriate for the gender
- Can be complete (i.e., all sexual characteristics develop prematurely) or incomplete (i.e., only one sexual characteristic develops prematurely)
Heterosexual
- Virilization/masculinization of girls or feminization of boys
- In girls, most commonly results from congenital adrenal hyperplasia (CAH), exposure to exogenous androgens, or androgen-secreting neoplasm
Difference between Complete and Incomplete Isosexual Precocious Puberty
Complete isosexual: normal pubertal changes take place but at earlier-than-normal age
Incomplete isosexual: premature breast budding (i.e., thelarche), axillary hair growth, or pubic hair growth (i.e., pubarche) may take place
Precocious puberty in boys age and most common cause
Precocious puberty in boys occurs <9 years and is most commonly caused by adrenal hyperplasia.
Isosexual precocious puberty - most common cause
Central nervous system lesions or traumas are causes of isosexual precocious puberty in approximately 10% of cases.
Labs for Precocious Puberty - All cases
Increased LH and FSH with an additional release following administration of gonadotropin-releasing hormone (GnRH) suggest central precocious puberty; low LH and FSH with no response to GnRH suggest pseudo precocious puberty
Increased estrogen in the presence of low LH and FSH suggests ectopic hormone production (neoplasm) or
consumption of exogenous estrogen; significantly high levels of adrenal steroids may be seen with neoplasm or CAH.
Increased thyroid-stimulating hormone (TSH) with low thyroxine (T4) and triiodothyronine (T3) suggests precocious puberty in response to chronic hypothyroidism.
The role of Radiology in Precocious Puberty
magnetic resonance imaging (MRI) or computed tomography (CT) with contrast may detect cerebral or adrenal lesions
Treatment of Precocious Puberty
GnRH analogs are useful for LH and FSH suppression in central precocious puberty
Precocious puberty secondary to ectopic hormone secretion should be treated by locating and removing the source of the hormone.
Precocious puberty caused by CAH should be treated with cortisol replacement
Complete precocious puberty with an onset close to the expected start of puberty may not require treatment
Incomplete precocious puberty requires only observation to make sure that it does not become complete precocity
Complications of Precocious Puberty
short stature (bones fuse at early age); social and emotional adjustment issues
The follicular phase of the Normal Menstrual Cycle
Begins at the first day of menses (i.e., menstruation
FSH stimulates the growth of ovarian follicles (granulosa cells), which in turn secretes estradiol.
Estradiol induces endometrial proliferation and further increases FSH and LH secretion from the positive feedback of the pituitary.
The luteal phase of the Normal Menstrual Cycle
LH surge induces ovulation. Ovulation is the transition from the follicular phase of the menstrual cycle to the luteal phase. Cervical mucus immediately before ovulation is copious, thick, and clear, which is an indication of LH surge.
Residual follicle (i.e., corpus luteum) secretes estradiol and progesterone to maintain endometrium and induce the development of secretory ducts.
High estradiol levels inhibit FSH and LH.
If the egg is not fertilized, corpus luteum degrades, progesterone and estradiol levels decrease, and the endometrial lining degrades (i.e., menses).
Luteinizing hormone (LH) effects
Midcycle surge induces ovulation
Regulates cholesterol conversion to pregnenolone in ovarian theca cells as initial step in estrogen synthesis
Follicle-stimulating hormone (FSH) effects
Stimulates development of ovarian follicle
Regulates ovarian granulosa cell activity to control estrogen synthesis
Estrogens (estradiol, estriol) effects
Stimulates endometrial proliferation Aids in follicle growth Induces LH surge High levels inhibit FSH secretion The principal role in sexual development
Progesterone effects
Stimulates endometrial gland development
Inhibits uterine contraction
Increases thickness of cervical mucus
Increases basal body temperature
Inhibits LH and FSH secretion; maintains pregnancy
The decrease in levels leads to menstruation
Human chorionic gonadotropin (hCG) effects
Acts like LH after implantation of fertilized egg
Maintains corpus luteum viability and progesterone secretion
What does the endometrial tissue secrets in order to maintain the corpus luteum
hCG
After which period of amenorrhea, a diagnosis of menopause can be achieved
One year of amenorrhea is required for a diagnosis of menopause.
Types of Menopause and Meaning
- Permanent end of menstruation because of ceasing of ovarian function in later middle age (∼51.5 years)
- Premature menopause is defined as an ovarian failure before age 40 years (more likely with a history of tobacco use, radiation therapy, chemotherapy, autoimmune disorders, or abdominal or pelvic surgery)
Menopause - Symptoms
H/P = hot flashes (secondary to thermoregulatory dysfunction), breast pain, sweating, menstrual irregularity with eventual amenorrhea, possible menorrhagia, fatigue, anxiety, irritability, depression, dyspareunia (caused by vaginal wall atrophy and decreased lubrication), urinary frequency, dysuria, change in bowel habits, sleep disturbances, decreased libido, cognitive decline; examination detects vaginal atrophy
Menopause - Labs
increased FSH, increased LH, decreased estradiol
Menopause - Treatment
a. Lubricating agents to treat dyspareunia (i.e., painful intercourse); short-term topical vaginal estrogen used in cases of significant vaginal symptoms
b. The first-line treatment for hot flashes is weight loss
c. Calcium, vitamin D, bisphosphonates, and exercise to prevent osteoporosis
d. Selective estrogen receptor modulators, such as raloxifene and tamoxifen, may serve a role in reducing osteoporosis and cardiovascular risks
e. Hormone replacement therapy poses an increased risk for breast cancer and deep vein thrombosis
Menopause - Complications
osteoporosis, coronary artery disease, dementia
Contraindication for Topical estrogen
Topical estrogen use is contraindicated in any patient with a history of breast cancer
Why is there an increased risk of osteoporosis?
Increased risk of osteoporosis in menopausal women is caused by decreased estrogen production by the ovaries.
Risk factors for osteoporosis
Risk factors for osteoporosis are advanced age, postmenopausal, low body weight, white or Asian, smoking, ETOH, and vitamin D deficiency
Contraception - Method Choice
- Should consider likelihood of patient compliance.
- Side effects must be tolerated by patient.
- Certain methods may be contraindicated for comorbid medical conditions
Hormonal Methods for Contraception
Hormonal Methods
- Oral contraceptive pills - combined formulation
- Oral contraceptive pills - progestin formulation
- Medroxyprogesterone acetate
- Progestin implant
- Transdermal contraceptive patch
- Intravaginal ring
- Emergency contraception
Barrier Methods for Contraception
- Condom
- Diaphragm or cervical cap
- Contraceptive sponge
- Spermicide alone
Sexual Practice Methods for Contraception
- Abstinence
- Rhythm method
- Withdrawal method
- Lactation
Intrauterine Devices and Surgical Method for Contraception
- Copper IUD
- Progestin-releasing IUD
Surgical: Sterilization
Types of Amenorrhea
Primary: the absence of menses (never has happened) with normal secondary sexual characteristics by a 16-year-old or absence of both menses and secondary sexual characteristics by a 13-year-old
Secondary: the absence of menses for 6 months or for >3 cycles in a patient with prior history of menses